Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xueying Zuo
Institutions:
Nanjing General Hospital of Nanjing Military Command,
Nanjing University
Observed institutions:
Nanjing General Hospital of Nanjing Military Command,
Nanjing University
ORCID:
0000-0001-6030-7782
Observed ORCID:
0000-0001-6030-7782
OpenAlex ID:
A5109717784
Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer
2020
·
Li Zhou
, Qiuli Xu
, et al.
·
Cancer Letters
·
111
Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta-analysis
2021
·
Jingyuan Xie
, Qin Wang
, et al.
·
Annals of Palliative Medicine
·
49
PDF
NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53/IRF1/type I interferon signaling axis
2024
·
Zimu Wang
, Jing Luo
, et al.
·
Cell Death Discovery
·
44
Intrapleural dual blockade of IL-6 and PD-L1 reprograms CAF dynamics and the tumor microenvironment in lung cancer-associated malignant pleural effusion
2025
·
Qinpei Cheng
, Xueying Zuo
, et al.
·
Respiratory Research
·
21
PDF
A random survival forest-based pathomics signature classifies immunotherapy prognosis and profiles TIME and genomics in ES-SCLC patients
2024
·
Yuxin Jiang
, Yueying Chen
, et al.
·
Cancer Immunology Immunotherapy
·
11
PDF
A novel oral TLR7 agonist orchestrates immune response and synergizes with PD-L1 blockade via type I IFN pathway in lung cancer
2024
·
Xueying Zuo
, Qinpei Cheng
, et al.
·
International Immunopharmacology
·
10
CD39+CD8+ T cell infiltration is associated with clinical outcomes of subsequent immunotherapy in advanced EGFR-mutant non-small cell lung cancer
2026
·
Wanjun Lu
, Qiuxia Wu
, et al.
·
Therapeutic Advances in Medical Oncology
Impact of chronic obstructive pulmonary disease on the prognosis of patients with extensive-stage small-cell lung cancer treated with chemoimmunotherapy
2026
·
Yuxin Jiang
, Yu Li
, et al.
·
Translational Lung Cancer Research
Show more works
View as search
Works count:
8
Citation count:
246
H-index:
6
I10-index:
6
Year
Topic
Type